
    
      This prospective randomized trial includes pregnant women with term pregnancies, indication
      for labor induction and an unfavorable cervix. These women are randomized into two groups:
      one group is induced using an intracervical prostaglandin E2 (PGE2, dinoprostone)
      formulation, the other using an intravaginal PGE2 formulation. Main outcome is time period
      between beginning of labor induction to delivery, and a reduction of four hours is considered
      clinically significant.
    
  